Panagora Asset Management’s REVIVA PHARMA HLDGS INC RVPH Stock Holding History

Panagora Asset Management’s Portfolio RVPH Stock Details RVPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-68	Closed	-$15K	–	2753
2020 Q2	$15K	Hold	68	–	–	﹤0.01%	2187
2020 Q1	$14K	Hold	68	–	–	﹤0.01%	2100
2019 Q4	$14K	Hold	68	–	–	﹤0.01%	2088
2019 Q3	$14K	Sell	68 -5,749	-99%	-$1.18M	﹤0.01%	2126
2019 Q2	$1.19M	Hold	5,817	–	–	0.01%	1055
2019 Q1	$1.17M	Hold	5,817	–	–	0.01%	1054
2018 Q4	$1.15M	Buy	+5,817	New	+$1.14M	0.01%	1018

Other funds holding RVPH

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

MSU

Mizuho Securities USA New York $6.2B AUM 35.46% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return

YCM

Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return

WRBC

W.R. Berkley Corp Greenwich, Connecticut $1.86B AUM 14.44% 1-Year Est. Return

BCM

Basso Capital Management Stamford, Connecticut $469M AUM 32.23% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Walleye Trading New York $87.6B AUM 68.17% 1-Year Est. Return

Panagora Asset Management's RVPH Position: Q3 2020 in Review

Panagora Asset Management sold out of REVIVA PHARMA HLDGS INC (RVPH) in Q3 2020, closing a stake of 68 shares — an estimated $15K sold.

Panagora Asset Management first reported a position in RVPH in Q4 2018 and held it in 7 quarters. The position peaked at $1.19M in Q2 2019. 13 funds tracked by Wall St. Rank hold RVPH as of Q3 2020.

Panagora Asset Management reported no remaining REVIVA PHARMA HLDGS INC position as of Q3 2020 after selling out during the quarter.
Panagora Asset Management sold 68 REVIVA PHARMA HLDGS INC shares in Q3 2020, an estimated $15K.
Panagora Asset Management first reported a position in REVIVA PHARMA HLDGS INC in Q4 2018 and held it in 7 quarters.
Panagora Asset Management's REVIVA PHARMA HLDGS INC position peaked at $1.19M in Q2 2019.
13 funds tracked by Wall St. Rank held REVIVA PHARMA HLDGS INC as of Q3 2020.

Based on Panagora Asset Management's 13F filing for Q3 2020, filed 13 Nov 2020.